| Not Yet Recruiting | Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Adenocarcinoma of Gastric, Adenocarcinoma of Esophagogastric Junction | Phase 1 | 2026-03-05 |
| Not Yet Recruiting | Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Ery Difficult to Treat Systemic Lupus Erythematosus | EARLY_Phase 1 | 2025-03-31 |
| Not Yet Recruiting | Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2025-02-20 |
| Recruiting | Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer Colorectal Cancer (CRC) | Phase 1 | 2024-12-15 |
| Not Yet Recruiting | IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients IgA Nephropathy, Membranous Nephropathy | EARLY_Phase 1 | 2024-12-13 |
| Not Yet Recruiting | WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients Recurrent or Progressive Glioblastoma | EARLY_Phase 1 | 2024-11-12 |
| Not Yet Recruiting | IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma Refractory Osteosarcoma, Recurrent Osteosarcoma | Phase 1 | 2024-06-15 |
| Unknown | INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia Leukemia, B-cell | Phase 1 | 2024-01-15 |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractor Leukemia | EARLY_Phase 1 | 2022-07-11 |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractor Leukemia | Phase 1 / Phase 2 | 2022-04-01 |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Diges Advanced Solid Tumors, Digestive System Neoplasms, Pancreatic Cancer Resectable | EARLY_Phase 1 | 2022-03-10 |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastr Advanced Solid Tumors, Gastric Cancer, Esophagogastric Junction Cancer | EARLY_Phase 1 | 2022-02-15 |
| Unknown | Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tum Melanoma, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2022-01-01 |
| Unknown | Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) M Lymphoma, Lymphoma, Mantle-Cell, Neoplasms by Histologic Type | Phase 1 / Phase 2 | 2021-12-31 |
| Unknown | Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors Liver Cancer | Phase 1 | 2021-08-24 |
| Unknown | Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractor Multiple Myeloma | EARLY_Phase 1 | 2021-05-06 |
| Unknown | Donor-derived CAR-T Cells in the Treatment of AML Patients AML | Phase 1 | 2021-03-01 |
| Unknown | Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients Wi Multiple Myeloma | Phase 1 | 2020-09-03 |
| Recruiting | Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patien NHL | Phase 1 / Phase 2 | 2020-06-04 |
| Unknown | Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation Leukemia | N/A | 2019-01-01 |
| Unknown | Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors Hepatocellular Carcinoma , Cholangiocarcinoma | EARLY_Phase 1 | 2019-01-01 |
| Completed | Safety and Efficacy Evaluation of IM23 CAR-T Cells (IM23CAR-T) AML | Phase 1 | 2018-07-21 |
| Unknown | Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients Non Hodgkin Lymphoma | Phase 1 | 2018-05-22 |
| Unknown | Safety and Efficacy Evaluation of Decitabine With R-GDP NHL | Phase 1 | 2017-09-01 |
| Unknown | Safety and Efficacy Evaluation of IM19 Cells Hematological Malignancies | Phase 1 | 2017-08-21 |
| Completed | Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T) Leukemia | Phase 1 / Phase 2 | 2017-05-23 |
| Unknown | Safety and Efficacy Evaluation of IM19 CAR-T Cells Leukemia | Phase 1 / Phase 2 | 2016-08-30 |